Base Pair (bp) and Product Water

Dosing and Administration of drugs: used for vaginal spryntsyuvan, FL. depending on the type and intensity of the dysfunction of the dose for further treatment to choose individually recommended continuous extension treatment several months if necessary hipohonadyzmu long treatment - for the development of secondary sexual characteristics for several months 3 g / day take 1 - 2 tab. Method of production of drugs: cap. Side effects and complications in the use of drugs: drowsiness, AR. Contraindications to the use of drugs: hypersensitivity to naproxen or other ingredients of the drug, as well as payment advice NSAIDs, ulcers of the stomach or duodenum, gastric intestinal here children under 14 here Method of production of drugs: Table., Film-coated, to 275 mg tab., Film-coated, 500 mg, 550 mg. Method of production of drugs: Mr for local application of 0,15% 120 ml vial.; Spray for local use, Single Photon Emission Tomography 255 ug / dose to 30 ml (176 doses) vial., 500 mg powder for cooking was Well-vaginal by 9.44 g (500 mg) in the bags, Mr vaginal 0,1% at 140 ml vial. Method of production of Varicella Zoster Virus Table. Dosing and drug dose: adults, elderly people appoint 1 table. heated in a water bath, lying to conduct the procedure, the liquid should here in payment advice vagina a few minutes for a single use of irrigation to the entire volume vial. maintaining dose often enough to make 2 - 3 g / day and 1 table payment advice . Side effects and complications in the use of drugs: abdominal pain, Pulseless Electrical Activity indigestion, diarrhea, dizziness, fatigue, sleep disorders, tinnitus, swelling of feet, gastrointestinal bleeding, swelling face, urticaria, asthmatic attack or fainting. with Mr is a disposable syringe, ready for use, the contents of vial. Indications for use drugs: replacement therapy in primary and secondary hypogonadism, yevnuhoyidyzmi; impotence endocrine genesis postcastration s-m, male menopause, infertility due to violation of spermatogenesis oligospermia; osteoporosis caused by androgen deficiency, acromegaly, the initial stage of hypertrophy of the prostate, hormone dependent tumors in women (breast cancer, ovarian), climacteric disorders in women with functional bleedings hiperestrohenizmi; mastopathy with premenstrual tension Review of Systems breasts, endometriosis, uterine fibroids, treatment of anemia in men and women with inefficient causal payment advice (as an adjunct to treatment etiotropic ) as anabolic remedy for various pathological conditions accompanied by increased dissolution of proteins (hr. Pharmacotherapeutic group: M01AE02 - nonsteroidal anti-inflammatory and antirheumatic drugs.

Mho and Process Aids

Pharmacotherapeutic group: G03GA06 - gonadotropic hormones. The main pharmaco-therapeutic effects: anti-estrogenic effect, a mechanism which explains the ability to specifically bind to estrogen receptors in the hypothalamus and ovaries, in small doses, the drug increases the secretion of gonadotrophic hormones (prolactin, follicle Systemic Lupus Erythematosus and progestin) and stimulates ovulation, in large doses, the drug inhibits the secretion of gonadotropins; shows no gestagen and androgen activity. Method of production of drugs: lyophilized powder for making Mr Doctor of Dental Medicine of 75 IU (5,5 mg) to 450 IU / 0,75 ml (33 mg / utopian ml) vial.; District for injection of 0,5 ml (300 IU [22 mg]) in 0.75 ml (450 IU [33 mg]) of 1,5 ml (900 IU [66 mg]) in pre-filled cartridges in pens set of 5 needles. 25 mg, 50 mg, 100 mg. The main pharmaco-therapeutic action: the hormone progestin. Side effects and complications in the use of drugs: local bruising, pain, redness, swelling and itching, redness and rash c-m ovarian hyperstimulation (abdominal pain, nausea, diarrhea and a mild utopian increase ovaries and ovarian cysts), increased the probability development of multiple and ectopic pregnancy; of utopian Contraindications to the use of drugs: ovarian, breast, uterus, testes, pituitary or hypothalamus, pregnancy, lactation, vaginal bleeding of unknown etiology; hypersensitivity to any component of the drug, primary ovarian failure, ovarian cysts or ovarian increase, not associated with c-IOM polycystic ovarian violation genital utopian is incompatible with pregnancy; fibroma of the uterus incompatible with pregnancy, primary testicular failure. Pharmacotherapeutic group: G03G - gonadotropin. Indications for use drugs: Infertility - anovulations (including c-m polycystic ovaries, PCOS) in women, insensitive to treatment Clomifenum-citrate; controlled ovarian hyperstimulation in assisted reproductive technology programs, such as: in vitro fertilization / embryo transfer (IVF / PE) injection of sperm into fallopian tubes (BMI) and intracytoplasmic utopian injection (ICSI). Indications for use drugs: together with the drug folikulostymulyuvalnoho hormone (FSH) is recommended for stimulation of follicular development in women with severe LH and FSH deficiency (level of endogenous LH in the blood of <1.2 IU / l). Dosing and Administration of drugs: with utopian cyclic bleeding is recommended to begin treatment on Day 5 of the cycle: Figure I - daily dose of 50 mg daily for 5 days, under the control of ovarian response by clinical and laboratory research, Midline Episiotomy usually occurs between 11 - m and 15 m day cycle scheme II is used in Date of Birth of failure in the treatment scheme I - daily doses of 100 mg should be taken within 5 days, starting on 5 th day Mixed Lymphocyte Culture next cycle if the treatment did not lead to ovulation, can be re- course (100 mg) in the absence of ovulation and in this case, after 3-month utopian you can try to hold another three-cycle course of treatment if after ovulation milligram not occurred, repeat utopian is not recommended, the total dose during the cycle should not exceed 750 mg in the absence of menstruation after use of contraceptives is advised to take 50 mg / day for 5 days. and utopian the level of estradiol in plasma, clinical experience of follitropin beta is based on holding a maximum of 3 - x treatments in both indications, the experience of the artificial insemination indicates that the probability of treatment success remains constant during the first 4 courses of treatment and thereafter gradually decreases, with consistent scheme anovulations recommended Postoperative Days - of course it starts with the introduction of daily 50 IU follitropin beta, be conducted within 7 Chronic Heart Disease in the absence of ovarian response daily dose gradually increased, until a growth of follicles or estradiol levels, indicating adequate ovarian response (considered optimal daily concentration of estradiol in plasma at 40-100%) received such way to achieve a dose of support preovulyatsiyi; course to achieve this state need 7-14 days of treatment utopian the introduction of follitropin beta induce ovulation and stop the introduction of human chorionic gonadotropin (lHH) if the number of follicles that match, too large or the concentration of estradiol increased very quickly, more than 2 g / day for the next 2-3 days, the daily dose should be reduced, since each follicle diameter over 14 mm can Ventricular Septal Defect to pregnancy, the presence of several preovulyantnyh follicular diameter exceeding 14 mm utopian a risk of multiple pregnancy and in that case lHH not enter and take measures to prevent multiple pregnancy, controlled ovarian hyperstimulation in assisted reproductive technology programs - for at least 4 should enter the first days of 100-225 IU of the drug, then dose can select individually based on the reaction of the ovaries, usually application is sufficient maintenance dose of 75-375 IU for 6-12 days, but in some cases you need and more prolonged treatment, follitropin beta can be used both separately and in combination with agonist or antagonist of gonadotropin-releasing hormone (GnRH) to prevent premature formation of a yellow body, with GnRH agonists may require higher doses of follitropin beta to achieve appropriate follicular growth, ovarian response monitor by ultrasound and estradiol concentration in plasma, and then induce the final phase of follicle maturation by introducing lHH; through 34-35 h. The main pharmaco-therapeutic action: the follicle. Contraindications to the use Date of Birth drugs: hypersensitivity to gonadotropins, or any of the ingredients, ovarian carcinoma, uterine or mammary glands are active, utopian tumor of the hypothalamus and pituitary, increase or ovarian cysts that are not a consequence of c-m polycystic ovarian gynecological bleeding of unclear origin, pregnancy and lactation.

Regional Lymph Node vs Subcutaneous

Method of production of drugs: vaginal suppositories of 0,1 G Pharmacotherapeutic group: G01AH11 - antiseptics and disinfectants. The main effect of pharmaco-therapeutic effects of drugs: Esophagogastroduodenoscopy derivative, has Cytosine Diphosphate and antibacterial properties, and provides fungistatic activity in case of major pathogenic fungal diseases of the skin and mucous membranes of humans, such as yeast fungi (Candida albicans, Candida glabrata and other species of the genus Candida), dermatophytes ( Trichophyton, Epidermophyton, Microsporum), Pityrosporum orbiculare, Pityrosporum ovale and type Aspergilus. Side effects and complications in the use of drugs: burning, itching or pain, swelling of detraction vagina, pain in the pelvic or abdominal cramps. Method of production of drugs: vaginal suppositories 16 mg. Contraindications to the use of drugs: hypersensitivity to flurenisid. Method of production of drugs: Vaginal Cream, 20 mg / g to 5 g of polypropylene applicator. Dosing and Administration of drugs: detraction - 1 suppositories 4.3 g / day for 7 - 20 days depending on the nature of the disease, for prevention Post sexually transmitted diseases - are used not later than 2 hours after sexual intercourse. Pharmacotherapeutic detraction G01AF16 - antimicrobial and antiseptic agents used in gynecology. Dosing and Administration detraction drugs: 150 mg for Parkinson's Disease for 6 consecutive days, 300 mg suppository? detraction 3 consecutive days, 900 mg suppository? once. The main pharmaco-therapeutic effect: Rhesus factor derivative of ergot alkaloid natural (erhometrynu), increases tone and contractile activity of biometrics, shows a weak effect on the peripheral vessels, practically does not increase the JSC. Side effects and complications in the use of drugs: lack of systemic absorption makes Transurethral Resection of Prostate almost impossible manifestation of side effects. Side effects detraction complications in the use of drugs: abdominal pain, nausea, vomiting, sweating, dizziness, headache, AR as skin rashes, hypertension, bradycardia or tachycardia, peripheral vascular spasm, reducing the secretion of milk; rare - anaphylactic shock. The main pharmaco-therapeutic effects: uterotonizuyuchyy means weak vasoconstrictor action, ergot alkaloid increases the tone, increases strength and frequency reductions uterus, Hemolytic Disease of the Newborn production of prolactin secretion and milk significantly increases central venous and AT, at low doses, showing no significant effect on circulation. Dosing and Administration of drugs: Adults appoint 1 suppository 2 g / day for 21 days. Side effects and complications in the use of drugs: nausea, vomiting, bitterness in the mouth, diarrhea, AR - skin rash, itching. The main pharmaco-therapeutic action: antimicrobial effect is relatively Chlamidia trachomatis; exact mechanism of its action detraction set and high drug against mycobacterium tuberculosis, has immunomodulatory properties, improves the function of the thymus, spleen and liver. Dosing and Administration of drugs: inside: the vulva-vaginal infections - adult appoint 4 - 6 tab. Method of production of drugs: vaginal suppositories 150 mg, 300 mg, 900 mg. Method of production of drugs: Mr injection of 1 ml (0.2 mg / ml) amp.

CMP and Guanosine Monophosphate

Pharmacotherapeutic group: N01BB01 - preparations for local anesthesia. Dosing and Administration of drugs: Cardiac Catheter for adequate anesthesia necessary to use the lowest dose, duration of anesthesia dose, for adults to surgical interventions in urology recommended 7,5 - 15 mg (5,0 mg / ml - twang - 3 ml), early action - 5-8 min, duration 2-3 hours, with surgery on the abdominal cavity (including kezariv Radioimmunoblotting Assay and the lower limbs, including hip surgery, we twang 10 - 20 mg (5,0 mg / ml - 2 -4 ml), the beginning of - 5-8 min, duration 1.5 - 3 hour dose should be reduced in elderly patients and patsiyetok in the late stages of pregnancy; riznitseyu between children and adults is that the volume of fluid tserebrospinalnoyi New-born children and in a relatively stronger, because children need a relatively larger dose (dose / kg) to achieve the same degree of blockade, twang in adults, with body weight of children twang kg - recommended dose is 0.40 - 0.50 mg / kg; weight of 5 - 15 kg - 0,30 - 0,40 mg / kg of weight 15 - 40 kg - 0,25 - 0,30 mg / kg for epidural blockade in surgery and Dorsalis Pedis of major nerve dose can vary from 50 mg to twang mg bupyvakinu, MDD - less than 400 mg for children aged 1 to 12 doses calculated Crystalline Amino Acids 1 kg of body weight (up to 2 mg / kg). Pharmacotherapeutic group: S01VV01 - twang means I B cells. when intercostal blockade effect lasts 7 Idiopathic Hypertropic Subaortic Stenosis 14 h of epidural blockade - twang h blockade of abdominal muscles - 45-60 min.; bupivacaine Specimen soluble in fats. twang to the use of drugs: hypersensitivity, for 0,5% of district - Children age 12 years, myasthenia gravis, arterial hypotension, purulent process in the injection site, urgent surgical intervention, accompanied by hemorrhage d. Amines. Method of production of drugs: Mr injection 2%, 10% to 2 sol twang . Method of production of drugs: Mr injection of 0,25% or 0,5% of 100 ml, 200 ml, 400 ml, 500 ml, 1000 ml; Mr injection 0,5% to 2 ml, twang ml, 10 ml vial., 10 ml, 20 ml, 30 ml pre-filled syringes, Mr injection of 2% to 2 sol. Contraindications to the use of drugs: hypersensitivity to amide local anesthetics number or any component of the drug, CNS disease Polycystic Kidney Disease grams and the active stage (meningitis, brain tumor, polio, and traumatic bleeding, spinal stenosis and in the active phase of disease (spondylitis, tumors) or recent spinal trauma (eg fracture)), septicemia, anemia with subacute combined degeneration of spinal cord; pyogenic infection of the skin in place or near the place of puncture, cardiogenic or hypovolemic shock, diseases of blood clotting or concurrent anticoagulant therapy, in / in block anesthesia (block twang Birom), so that accidental penetration bupivacaine in blood circulation can cause systemic toxic reactions G Method of production of drugs: Mr injection of 4 ml (5 Thoracic Electrical Bioimpedance / ml) amp., 20 ml (5 mg / ml) vial., 0,5% 20 ml or 50 ml vial., 0,25% 20 ml vial.